Chong Li, MD
Vascular Surgery · Darien, CTNPI 1467941203
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,171 of the $13,179 with a category attached, or 62.0%. It is spread thinly across 32 manufacturers, the largest accounting for just 19.3%. 2025 is the largest year on record at $5,044, more than ten times the $216 reported in 2020.
Across 129 payments — averaging $102.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$3K
- Medtronic$2K
- Cook Medical LLC$1K
- Penumbra, Inc.$1K
- Mozarc Medical US LLC$1K
- Globus Medical$632
- plus $5K from 26 others
What the payments were for
- Speaking & faculty fees$2,55019%
- Travel & lodging$1,94115%
- Food & beverage$8,17162%
- Education$5174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 1 | $2,550 |
| Medtronic(2 entities) | 22 | $1,528 |
| Cook Medical LLC | 23 | $1,326 |
| Penumbra, Inc. | 15 | $1,271 |
| Mozarc Medical US LLC | 7 | $1,165 |
| Globus Medical | 2 | $632 |
| Shockwave Medical, Inc | 4 | $610 |
| Endologix LLC | 4 | $610 |
| Inari Medical, Inc. | 4 | $482 |
| Philips North America LLC | 6 | $443 |
| Bolton Medical Inc | 5 | $414 |
| Cardiva Medical, Inc. | 3 | $271 |
| Stryker | 4 | $238 |
| Silk Road Medical, Inc. | 2 | $186 |
| Surmodics, Inc. | 1 | $169 |
| Bard Peripheral Vascular, Inc. | 1 | $160 |
| Baxter Healthcare | 2 | $155 |
| Veryan Medical Incorporated | 2 | $150 |
| Boston Scientific | 1 | $149 |
| Tactile Systems Technology Inc | 1 | $143 |
| Organogenesis Inc. | 2 | $142 |
| Abbott | 3 | $74 |
| Cardiovascular Systems Inc. | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 2 | $50 |
| Lemaitre Vascular, Inc. | 2 | $43 |
| W. L. Gore & Associates, Inc. | 1 | $32 |
| Cvrx, Inc. | 1 | $27 |
| Smith+Nephew | 1 | $27 |
| BD | 1 | $26 |
| Johnson & Johnson | 1 | $19 |
| Cordis US CORP. | 1 | $17 |
| Kerecis Limited | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Argyle$1,201
- ExcelsiusGPS Robotic Navigation System$632
- ENDURANT IIS$601
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$591
- RUBY Coil$546
- Indigo System$519
- ROSEN$455
- FLOWTRIEVER CATHETER, S$445
- CT THROMBECTOMY SYSTEM KIT$445
- TREO ABDOMINAL STENT-GRAFT SYSTEM$309
- AFX2 Bifurcated Endograft System$286
- Pounce Thrombectomy System$169
- Pounce Venous Thrombectomy System$169
- Pounce Thrombectomy$169
- ENROUTE Transcarotid Stent$168
- ENROUTE Transcarotid Neuroprotection System$168
- VENOVO$160
- ELUVIA$149
- Alto Abdominal Stent Graft System$146
- Flexitouch Plus$143
How this compares
$13,179 in reported general payments places this provider in the 65th percentile of 82 vascular surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $27,844 |
| XareltoRivaroxaban | 28 | $24,876 |
| ClopidogrelClopidogrel Bisulfate | 68 | $823 |
| Gabapentin | 18 | $359 |
| Cilostazol | 11 | $275 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $108 |
| Prednisone | 20 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $19 | $24,87628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 82 vascular surgery providers in Connecticut.
Other vascular surgery in Darien
- Paul GagneDarien$766K
- Jonathan BowmanDarien$53K
- Timothy ManoniDarien$46K
- Taras KucherDarien$38K
- Ben MarsanDarien$36K
- Benjamin ChandlerDarien$8K
- Andrew LazarDarien$4K
- Uwe FischerNew London$941K
- Naiem NassiriNew Haven$348K
- Lee GoldsteinStratford$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.